TORONTO, March 2, 2017 /CNW/ - George Weston Limited (TSX: WN) ("GWL" or the "Company")
today announced its consolidated unaudited results for the 12 weeks ended December 31, 2016.
GWL's 2016 Annual Report includes the Company's audited annual consolidated financial statements and Management's Discussion
and Analysis ("MD&A") for the fiscal year ended December 31, 2016. The 2016 Annual Report
has been filed with SEDAR and is available at sedar.com and in the Investor Centre section of the Company's website at
weston.ca.
Galen Weston, Chairman and Chief Executive Officer, George Weston Limited, commented that
"George Weston Limited's fourth quarter results reflect the successful execution of the strategic priorities by both of the
Company's operating segments. Loblaw delivered strong results as it remained focused on its financial plan in a highly
competitive environment with continued pressures of healthcare reform. Weston Foods delivered results in line with expectations
driven by volume growth and productivity improvements as it continued to invest in the business."
2016 FOURTH QUARTER HIGHLIGHTS
|
|
|
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
($ millions except where otherwise indicated)
|
|
Quarters Ended
|
|
|
|
Years Ended
|
|
|
For the periods ended as indicated
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Change
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015(3)
|
|
Change
|
Sales
|
|
$
|
11,519
|
|
$
|
11,248
|
|
2.4%
|
|
$
|
47,999
|
|
$
|
46,894
|
|
2.4%
|
Operating income
|
|
$
|
491
|
|
$
|
421
|
|
16.6%
|
|
$
|
2,255
|
|
$
|
1,929
|
|
16.9%
|
Adjusted EBITDA(1)
|
|
$
|
1,027
|
|
$
|
946
|
|
8.6%
|
|
$
|
4,140
|
|
$
|
3,826
|
|
8.2%
|
Adjusted EBITDA margin(1)
|
|
|
8.9%
|
|
|
8.4%
|
|
|
|
|
8.6%
|
|
|
8.2%
|
|
|
Net earnings attributable to shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
of the Company
|
|
$
|
92
|
|
$
|
148
|
|
(37.8)%
|
|
$
|
550
|
|
$
|
511
|
|
7.6%
|
Net earnings available to common
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shareholders of the Company
|
|
$
|
82
|
|
$
|
138
|
|
(40.6)%
|
|
$
|
506
|
|
$
|
467
|
|
8.4%
|
Adjusted net earnings available to common
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
shareholders of the Company(1)
|
|
$
|
204
|
|
$
|
183
|
|
11.5%
|
|
$
|
838
|
|
$
|
717
|
|
16.9%
|
Diluted net earnings per common share ($)
|
|
$
|
0.64
|
|
$
|
1.08
|
|
(40.7)%
|
|
$
|
3.90
|
|
$
|
3.62
|
|
7.7%
|
Adjusted diluted net earnings per
common share(1) ($)
|
|
$
|
1.59
|
|
$
|
1.43
|
|
11.2%
|
|
$
|
6.49
|
|
$
|
5.57
|
|
16.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED RESULTS OF OPERATIONS
Net earnings available to common shareholders of the Company decreased by $56 million ($0.44 per common share) to $82 million ($0.64 per common share) in the
fourth quarter of 2016 compared to the same period in 2015. The decrease was primarily due to the unfavourable year-over-year net
impact of certain adjusting items, as described below, partially offset by the increase in Loblaw Companies Limited ("Loblaw")
earnings and the positive contribution from the increase in the Company's ownership interest in Loblaw, as a result of Loblaw's
share repurchases. The increase in Loblaw earnings was primarily due to improvements in the underlying operating performance of
its Retail segment, including the favourable impact of a decrease in depreciation and amortization.
The unfavourable year-over-year net impact of certain adjusting items totaling $77 million ($0.60 per common share) was primarily due to:
- foreign currency translation of $52 million ($0.40 per common
share);
- asset impairments, net of recoveries, of $42 million ($0.32 per
common share); and
- a fair value adjustment of the forward sale agreement for 9.6 million Loblaw common shares of $39
million ($0.29 per common share);
partially offset by,
- the favourable impact of the impairment of Loblaw's drug retail ancillary assets held for sale in the fourth quarter of
2015 of $37 million ($0.28 per common share); and
- the favourable impact of Loblaw's accelerated transition of certain grocery stores to more cost effective and efficient
Labour Agreements in the fourth quarter of 2015 of $18 million ($0.14 per common share).
Adjusted net earnings available to common shareholders of the Company(1) increased by $21 million
($0.16 per common share) to $204 million ($1.59 per common
share) in the fourth quarter of 2016 compared to the same period in 2015, primarily due to the increase in Loblaw earnings and
the positive contribution from the increase in the Company's ownership interest in Loblaw, as described above.
REPORTABLE OPERATING SEGMENTS
The Company has two reportable operating segments, Loblaw and Weston Foods. The Company also holds cash, short term
investments and an interest in Choice Properties Real Estate Investment Trust ("Choice Properties") of 6%. Loblaw has three
reportable operating segments including retail businesses, a bank and Choice Properties. Loblaw provides Canadians with grocery,
pharmacy, health and beauty, apparel, general merchandise, retail banking, credit card services, insurance and wireless mobile
products and services. Loblaw also holds an 83% effective interest in Choice Properties, which owns, manages and develops retail
and commercial properties across Canada. The Weston Foods operating segment includes a leading
fresh bakery business in Canada and frozen, artisan bakery and biscuit businesses throughout
North America.
Weston Foods Segment Results
(unaudited)
|
|
|
|
|
|
|
($ millions except where otherwise indicated)
|
|
Quarters Ended
|
|
|
Years Ended
|
|
For the periods ended as indicated
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Change
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Change
|
Sales
|
|
$
|
537
|
|
$
|
527
|
|
1.9%
|
|
$
|
2,268
|
|
$
|
2,144
|
|
5.8%
|
Operating income
|
|
$
|
38
|
|
$
|
42
|
|
(9.5)%
|
|
$
|
173
|
|
$
|
177
|
|
(2.3)%
|
Adjusted EBITDA(1)
|
|
$
|
73
|
|
$
|
67
|
|
9.0%
|
|
$
|
296
|
|
$
|
285
|
|
3.9%
|
Adjusted EBITDA margin(1)
|
|
|
13.6%
|
|
|
12.7%
|
|
|
|
|
13.1%
|
|
|
13.3%
|
|
|
Depreciation and amortization(i)
|
|
$
|
27
|
|
$
|
25
|
|
8.0%
|
|
$
|
111
|
|
$
|
94
|
|
18.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Depreciation and amortization in the fourth quarter of 2016 includes
$3 million (2015 – $6 million) and year-to-date $14 million (2015 – $11 million) of
accelerated depreciation related to restructuring and other charges.
|
Sales Weston Foods sales in the fourth quarter of 2016 were $537 million, an increase of $10 million,
or 1.9%, compared to the same period in 2015, primarily due to an increase in volumes. Foreign currency translation had a nominal
negative impact on sales compared to the same period in 2015.
Operating income Weston Foods operating income in the fourth quarter of 2016 was $38 million, a decrease of
$4 million, or 9.5%, compared to the same period in 2015. The decrease was due to the unfavourable year-over-year net impact
of certain adjusting items and an increase in depreciation and amortization, partially offset by an improvement in underlying
operating performance, as described below. The unfavourable year-over-year net impact of certain adjusting items was primarily
due to:
- charges associated with damaged inventory in the fourth quarter of 2016 of $5 million;
and
- the fair value adjustment of derivatives of $4 million;
partially offset by,
- the favourable impact of settlement charges related to pension annuities and buy-outs in the fourth quarter of 2015 of
$3 million.
Adjusted EBITDA (1) Weston Foods adjusted EBITDA(1) in the fourth quarter of 2016 was
$73 million, an increase of $6 million, or 9.0%, compared to the same period in 2015. The increase was driven by
the positive impact of the increase in sales and productivity improvements, partially offset by continued investments in the
business and higher input costs.
Adjusted EBITDA margin(1) in the fourth quarter of 2016 was 13.6% compared to 12.7% in the same period in
2015. The improvement in adjusted EBITDA margin(1) in the fourth quarter of 2016 was mainly due to the factors
impacting adjusted EBITDA(1), as described above.
Depreciation and Amortization Weston Foods depreciation and amortization was $27 million in the fourth
quarter of 2016, an increase of $2 million compared to the same period in 2015. Depreciation and amortization in the fourth
quarter of 2016 included $3 million (2015 – $6 million) of accelerated depreciation related to the planned closures of
bread, pie and cake manufacturing facilities. Excluding these amounts, depreciation and amortization increased by $5 million
due to investments in capital.
Weston Foods Other Business Matters
Restructuring Weston Foods continuously evaluates strategic and cost reduction initiatives related to
its manufacturing assets, distribution networks and administrative infrastructure with the objective of ensuring a low cost
operating structure. Weston Foods recorded restructuring and other charges in the fourth quarter of 2016 of
$7 million (2015 – $8 million) and year-to-date of $17 million (2015 – $26 million), including
$3 million (2015 – $6 million) and $14 million (2015 – $11 million) of accelerated depreciation. These
charges primarily relate to restructuring plans to close manufacturing facilities in Canada and
the U.S. with production transferring to other facilities.
Inventory loss In the fourth quarter of 2016 and year-to-date, Weston Foods recorded $5 million
(U.S. $4 million) and $11 million (U.S. $9 million), respectively, related to the write-off of damaged
inventory and other associated costs in selling, general and administrative expenses ("SG&A") in the Company's
consolidated statement of earnings. An insurance claim is in progress and proceeds are expected to be recorded as the claim
progresses.
Loblaw Segment Results
(unaudited)
|
|
|
|
|
|
|
($ millions except where otherwise indicated)
|
|
Quarters Ended
|
|
|
Years Ended
|
|
|
For the periods ended as indicated
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Change
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Change
|
Sales
|
|
$
|
11,130
|
|
$
|
10,865
|
|
2.4%
|
$
|
46,385
|
|
$
|
45,394
|
|
2.2%
|
Operating income
|
|
$
|
447
|
|
$
|
314
|
|
42.4%
|
$
|
2,084
|
|
$
|
1,593
|
|
30.8%
|
Adjusted EBITDA(1)
|
|
$
|
954
|
|
$
|
879
|
|
8.5%
|
$
|
3,844
|
|
$
|
3,541
|
|
8.6%
|
Adjusted EBITDA margin(1)
|
|
|
8.6%
|
|
|
8.1%
|
|
|
8.3%
|
|
7.8%
|
|
|
Depreciation and amortization(i)
|
|
$
|
365
|
|
$
|
376
|
|
(2.9)%
|
$
|
1,543
|
|
$
|
1,592
|
|
(3.1)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Depreciation and amortization includes $124 million (2015 –
$124 million) in the fourth quarter of 2016 and $535 million (2015 – $536 million) year-to-date of
amortization of intangible assets acquired with Shoppers Drug Mart Corporation ("Shoppers Drug Mart").
|
Sales, operating income and adjusted EBITDA(1) in the fourth quarter of 2016 included the impacts related to the
franchises consolidated in the quarter, as set out in "Loblaw Other Business Matters".
Sales Loblaw sales in the fourth quarter of 2016 were $11,130 million, an
increase of $265 million compared to the same period in 2015, primarily driven by Retail. Retail sales increased by
$239 million, or 2.3%, compared to the same period in 2015 and included food retail sales of $7,789 million (2015 – $7,631 million) and drug retail sales of
$3,056 million (2015 – $2,975 million).
Excluding the consolidation of franchises, Retail sales increased by $168 million primarily driven by the following
factors:
- food retail same-store sales growth was 1.1%. The same-store sales growth includes the impact of retail promotional
investments. Food retail same-store sales included the favourable impact of an extra selling day in the fourth quarter of 2016,
due to the timing of New Year's Day, of approximately 1.0%. Loblaw's food retail average
quarterly internal food price index declined and was slightly lower than the average quarterly national food price deflation of
2.3% as measured by "The Consumer Price Index for Food Purchased from Stores" ("CPI"). CPI does not necessarily reflect the
effect of inflation on the specific mix of goods sold in Loblaw stores;
- drug retail same-store sales growth was 3.4%, including same-store pharmacy sales growth of 2.5% and same-store front store
sales growth of 4.1%. Drug retail same-store sales included the favourable impact of an extra selling day in the fourth quarter
of 2016, due to the timing of New Year's Day, of approximately 0.6%; and
- in the last 12 months, Retail net square footage increased 0.3 million square feet, or 0.4%, primarily driven by new store
openings, partially offset by Loblaw's store closure plan announced in 2015 and completed in 2016.
Operating income Loblaw operating income in the fourth quarter of 2016 was $447 million, an increase of
$133 million compared to the same period in 2015, primarily driven by the improvements in underlying operating performance
of $86 million and the favourable year-over-year net impact of certain adjusting items totaling $47 million, as
described below:
- the improvements in underlying operating performance were primarily driven by Retail including higher sales with stable
gross margins, lower SG&A, lower depreciation and amortization and the favourable impact of the consolidation of
franchises; and
- the favourable year-over-year net impact of certain Retail adjusting items totaling $47
million was primarily due to:
- the impairment of drug retail ancillary assets held for sale in the fourth quarter of 2015 of $112 million;
- the accelerated transition of certain Loblaw's grocery stores to more cost effective and efficient Labour Agreements of
$55 million in the fourth quarter of 2015; and
- a charge related to inventory measurement of $33 million associated with the conversion
of Loblaw's franchised grocery stores to the new information technology ("IT") systems in the fourth quarter of 2015;
partially offset by,
- the unfavourable impact of asset impairments, net of recoveries, of $126 million; and
- the unfavourable impact of settlement charges related to pension annuities and buy-outs of $15
million.
Adjusted EBITDA (1) Loblaw adjusted EBITDA(1) in the fourth quarter of 2016 was
$954 million, an increase of $75 million compared to the same period in 2015, primarily driven by Retail. Retail
adjusted EBITDA(1) was $889 million, an increase of $66 million driven by an increase in gross profit,
partially offset by an increase in SG&A.
- Retail gross profit percentage of 27.2% increased by 40 basis points compared to the fourth quarter of 2015. Excluding the
consolidation of franchises, Retail gross profit percentage was 26.4%, a decrease of 20 basis points compared to the fourth
quarter of 2015. The decrease in gross profit was driven by food retail promotional investments, partially offset by
improvements in drug retail margins, due to strong front store performance, and improvements in shrink, driven by improved
inventory management.
- Retail SG&A as a percentage of sales was 19.0%, a decrease of 10 basis points compared to the fourth quarter of 2015.
Excluding the consolidation of franchises, SG&A decreased $9 million and as a percentage of
sales was 18.4%, an improvement of 40 basis points compared to the fourth quarter of 2015, driven by the following factors:
- lower store support costs;
- the positive impact of Loblaw's store closure plan announced in 2015 and completed in 2016; and
- favourable year-over-year foreign exchange impacts;
partially offset by,
- higher retail store costs as efficiencies achieved in retail stores were more than offset by an increase in financial
support to franchises.
Loblaw adjusted EBITDA(1) in the fourth quarter of 2016 also included an increase in Financial Services adjusted
EBITDA(1) of $5 million, primarily driven by growth in credit card receivables and higher Mobile Shop sales, and
an increase in Choice Properties adjusted EBITDA(1) of $4 million, primarily due to the expansion of
the portfolio through development of properties and an increase in base rent from existing properties.
Depreciation and Amortization Loblaw's depreciation and amortization was $365 million in the fourth
quarter of 2016, a decrease of $11 million compared to the same period in 2015. The decline in depreciation
and amortization was primarily attributable to a change in the estimated useful life of certain equipment and fixtures in
the second quarter of 2016.
Depreciation and amortization in the fourth quarter of 2016 included $124 million (2015 – $124 million) of
amortization of intangible assets acquired with Shoppers Drug Mart.
Loblaw Other Business Matters
Impairment of Ancillary Healthcare Business In the fourth quarter of 2016, a Shoppers Drug Mart
ancillary healthcare business was triggered for impairment testing due to impacts of Ontario
healthcare reform implemented in the long term care industry. Loblaw recorded a charge of $88 million related to the
impairment of fixed assets of $15 million and a customer relationship intangible asset of $73 million.
Consolidation of Franchises Loblaw has more than 500 franchise food retail stores in its network. As
at year end 2016, 200 of these stores were consolidated for accounting purposes under a new, simplified franchise agreement
("Franchise Agreement") implemented in 2015.
Loblaw will convert franchises to the Franchise Agreement as existing agreements expire, at the end of which all franchises
will be consolidated. The following table presents the number of franchises consolidated in the fourth quarter of 2016 and
year-to-date, and the total impact of the consolidation of franchises included in the consolidated results of the Company:
(unaudited)
|
|
Quarters Ended
|
|
Years Ended
|
($ millions except where otherwise indicated)
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
Number of Consolidated Franchise stores,
|
|
|
|
|
|
|
|
|
|
|
beginning of
period
|
|
165
|
|
|
43
|
|
85
|
|
|
Add: Number of Consolidated Franchise stores
|
|
|
|
|
|
|
|
|
|
|
|
in the period
|
|
35
|
|
|
42
|
|
115
|
|
85
|
Number of Consolidated Franchise stores, end
|
|
|
|
|
|
|
|
|
|
|
of period
|
|
200
|
|
|
85
|
|
200
|
|
85
|
Sales
|
|
$
|
99
|
|
$
|
28
|
|
$
|
363
|
|
$
|
56
|
Operating income (loss)
|
|
21
|
|
|
(7)
|
|
(1)
|
|
(17)
|
Adjusted EBITDA(1)
|
|
27
|
|
|
(4)
|
|
20
|
|
(12)
|
Depreciation and amortization
|
|
6
|
|
|
3
|
|
21
|
|
5
|
Net earnings (loss) attributable to
|
|
|
|
|
|
|
|
|
|
|
Non-Controlling
Interest
|
|
28
|
|
|
(4)
|
|
7
|
|
(9)
|
|
|
|
|
|
|
|
|
|
|
|
Operating income included in the table above does not significantly impact net earnings available to common shareholders of
the Company as this amount is largely attributable to Non-Controlling Interests.
Loblaw expects that the estimated impact in 2017 of new and current consolidated franchises will be revenue
of approximately $680 million, adjusted EBITDA(1) of approximately $55 million, depreciation and
amortization of approximately $45 million and net earnings attributable to Non-Controlling Interests of approximately
$10 million.
OUTLOOK (2)
Weston Foods expects sales growth generated by incremental capacity and productivity improvements to drive an
increase in adjusted EBITDA(1) in 2017 when compared to 2016. However, this improvement will be partially offset by
a challenging environment in our Canadian fresh bakery business and incremental investments required to meet new more
stringent regulatory requirements in food safety and labelling. The increase in adjusted EBITDA(1) is expected to
be greater in the second half of the year. Management expects to make capital investments of approximately $250 million
in 2017 related to growth, regulatory and maintenance. Depreciation is projected to increase in 2017 when compared to 2016, and
more than offset the improvement in adjusted EBITDA(1).
Loblaw remains focused on its strategic framework, delivering the best in food, best in health and beauty, operational
excellence and growth. This framework is supported by a financial plan of maintaining a stable trading environment that targets
positive same-store sales and stable gross margin, surfacing efficiencies to deliver operating leverage, and returning capital to
shareholders. In 2017, on a full year comparative basis, despite the current deflationary environment, Loblaw expects to:
- deliver positive same-store sales and stable gross margin in its Retail segment in a highly competitive grocery market with
continued negative pressure from healthcare reform;
- grow adjusted net earnings(1);
- invest approximately $1.3 billion in capital expenditures, including $1.0 billion in its Retail segment; and
- return capital to shareholders by allocating a significant portion of free cash flow to share repurchases.
For 2017, the Company expects growth in net earnings to be driven by an increase in net earnings at Loblaw, and the positive
impact of the Company's increased ownership in Loblaw as a result of Loblaw's share repurchases.
DECLARATION OF QUARTERLY DIVIDENDS
Subsequent to the end of the fourth quarter of 2016, the Company's Board of Directors declared a quarterly dividend on
GWL Common Shares, Preferred Shares, Series I, Preferred Shares, Series III, Preferred Shares, Series IV and Preferred
Shares, Series V payable as follows:
|
Common Shares
|
|
$0.44 per share payable April 1, 2017, to
shareholders of record March 15, 2017;
|
|
|
|
|
|
Preferred Shares, Series I
|
|
$0.3625 per share payable March 15, 2017, to
shareholders of record February 28, 2017;
|
|
|
|
|
|
Preferred Shares, Series III
|
|
$0.3250 per share payable April 1, 2017, to
shareholders of record March 15, 2017;
|
|
|
|
|
|
Preferred Shares, Series IV
|
|
$0.3250 per share payable April 1, 2017, to
shareholders of record March 15, 2017; and
|
|
|
|
|
|
Preferred Shares, Series V
|
|
$0.296875 per share payable April 1, 2017, to
shareholders of record March 15, 2017.
|
NON-GAAP FINANCIAL MEASURES
The Company uses the following non-GAAP financial measures: adjusted EBITDA and adjusted EBITDA margin, adjusted net
earnings attributable to shareholders of the Company, adjusted net earnings available to common shareholders of the Company and
adjusted diluted net earnings per common share. In addition to these items, the following measures are used by management in
calculating adjusted diluted net earnings per common share: adjusted operating income, adjusted net interest expense
and other financing charges, adjusted income taxes and adjusted income tax rate. The Company believes these non-GAAP
financial measures provide useful information to both management and investors in measuring the financial performance of the
Company for the reasons outlined below.
Management uses these and other non-GAAP financial measures to exclude the impact of certain expenses and income that must be
recognized under GAAP when analyzing consolidated and segment underlying operating performance. The excluded items are not
necessarily reflective of the Company's underlying operating performance and make comparisons of underlying financial performance
between periods difficult. From time to time, the Company may exclude additional items if it believes doing so would result in a
more effective analysis of underlying operating performance. The exclusion of certain items does not imply that they are
non-recurring.
These measures do not have a standardized meaning prescribed by GAAP and therefore they may not be comparable to similarly
titled measures presented by other publicly traded companies, and they should not be construed as an alternative to other
financial measures determined in accordance with GAAP.
For details on the nature of items excluded in the calculation of any of the non-GAAP financial measures detailed below, see
Section 18, "Non-GAAP Financial Measures", of the Company's 2016 Annual Report.
Adjusted EBITDA The Company believes adjusted EBITDA is useful in assessing and making decisions regarding the
underlying operating performance of the Company's ongoing operations and in assessing the Company's ability to generate cash
flows to fund its cash requirements, including its capital investment program.
The following table reconciles adjusted EBITDA to operating income, which is reconciled to GAAP net earnings attributable to
shareholders of the Company reported for the periods ended as indicated.
|
Quarters Ended
|
|
Dec. 31, 2016
|
|
|
|
Dec. 31, 2015
|
(unaudited)
($ millions)
|
Weston
Foods
|
Loblaw
|
Other (i)
|
Consolidated
|
|
Weston
Foods
|
Loblaw
|
Other(i)
|
Consolidated
|
Net earnings attributable to shareholders
|
|
|
|
|
|
|
|
|
|
|
|
of the Company
|
|
|
|
$
|
92
|
|
|
|
|
$
|
148
|
Add impact of the following:
|
|
|
|
|
|
|
|
|
|
|
Non-controlling interests
|
|
|
|
139
|
|
|
|
|
68
|
|
Income taxes
|
|
|
|
83
|
|
|
|
|
66
|
|
Net interest expense and other
|
|
|
|
|
|
|
|
|
|
|
|
financing charges
|
|
|
|
177
|
|
|
|
|
139
|
Operating income
|
$
|
38
|
$
|
447
|
$
|
6
|
$
|
491
|
|
$
|
42
|
$
|
314
|
$
|
65
|
$
|
421
|
Add impact of the following:
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets acquired
|
|
|
|
|
|
|
|
|
|
|
|
with Shoppers Drug Mart
|
|
124
|
|
124
|
|
|
124
|
|
124
|
|
Asset impairments, net of recoveries
|
|
130
|
|
130
|
|
|
4
|
|
4
|
|
Restructuring and other charges
|
7
|
2
|
|
9
|
|
8
|
(7)
|
|
1
|
|
Pension annuities and buy-outs
|
|
21
|
|
21
|
|
3
|
6
|
|
9
|
|
Fair value adjustment of derivatives
|
(1)
|
(6)
|
|
(7)
|
|
(5)
|
(6)
|
|
(11)
|
|
Charges related to retail locations in
|
|
|
|
|
|
|
|
|
|
|
|
Fort McMurray, net of recoveries
|
|
(5)
|
|
(5)
|
|
|
|
|
|
|
Drug retail ancillary assets
|
|
|
|
|
|
|
112
|
|
112
|
|
Inventory loss
|
5
|
|
|
5
|
|
|
|
|
|
|
Accelerated transition of Labour Agreements
|
|
|
|
|
|
|
55
|
|
55
|
|
Charge related to inventory measurement
|
|
|
|
|
|
|
|
|
|
|
|
and other conversion differences
|
|
|
|
|
|
|
33
|
|
33
|
|
Modifications to certain franchise fee
|
|
|
|
|
|
|
|
|
|
|
|
arrangements
|
|
|
|
|
|
|
(8)
|
|
(8)
|
|
Foreign currency translation
|
|
|
(6)
|
(6)
|
|
|
|
(65)
|
(65)
|
Adjusting items
|
$
|
11
|
$
|
266
|
$
|
(6)
|
$
|
271
|
|
$
|
6
|
$
|
313
|
$
|
(65)
|
$
|
254
|
Adjusted operating income
|
$
|
49
|
$
|
713
|
|
$
|
762
|
|
$
|
48
|
$
|
627
|
|
$
|
675
|
Depreciation and amortization excluding the
|
|
|
|
|
|
|
|
|
|
|
impact of the above adjustments(ii)
|
24
|
241
|
|
265
|
|
19
|
252
|
|
|
271
|
Adjusted EBITDA
|
$
|
73
|
$
|
954
|
|
$
|
1,027
|
|
$
|
67
|
$
|
879
|
|
$
|
946
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Represents the effect of foreign currency translation on a portion of the
U.S. dollar denominated cash and cash equivalents and short term investments held by foreign operations.
|
(ii)
|
Depreciation and amortization for the calculation of adjusted EBITDA
excludes $124 million (2015 – $124 million) of amortization of intangible assets, acquired with Shoppers
Drug Mart, recorded by Loblaw and $3 million (2015 – $6 million) of accelerated depreciation recorded by Weston
Foods, related to restructuring and other charges.
|
|
|
|
Years Ended
|
|
Dec. 31, 2016
|
|
|
|
Dec. 31, 2015(3)
|
(unaudited)
($ millions)
|
Weston
Foods
|
Loblaw
|
Other (i)
|
Consolidated
|
|
Weston
Foods
|
Loblaw
|
Other(i)
|
Consolidated
|
Net earnings attributable to shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
of the Company
|
|
|
|
$
|
550
|
|
|
|
|
$
|
511
|
Add impact of the following:
|
|
|
|
|
|
|
|
|
|
|
Non-controlling interests
|
|
|
|
540
|
|
|
|
|
319
|
|
Income taxes
|
|
|
|
465
|
|
|
|
|
418
|
|
Net interest expense and other
|
|
|
|
|
|
|
|
|
|
|
|
financing charges
|
|
|
|
700
|
|
|
|
|
681
|
Operating income
|
$
|
173
|
$
|
2,084
|
$
|
(2)
|
$
|
2,255
|
|
$
|
177
|
$
|
1,593
|
$
|
159
|
$
|
1,929
|
Add impact of the following:
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets acquired
|
|
|
|
|
|
|
|
|
|
|
|
with Shoppers Drug Mart
|
|
535
|
|
535
|
|
|
536
|
|
536
|
|
Asset impairments, net of recoveries
|
|
135
|
|
135
|
|
|
13
|
|
13
|
|
Restructuring and other charges
|
17
|
46
|
|
63
|
|
26
|
154
|
|
180
|
|
Pension annuities and buy-outs
|
3
|
23
|
|
26
|
|
3
|
8
|
|
11
|
|
Prior year tax assessment
|
|
10
|
|
10
|
|
|
|
|
|
|
Fair value adjustment of derivatives
|
(5)
|
5
|
|
|
|
(5)
|
(21)
|
|
(26)
|
|
Charges related to retail locations in
|
|
|
|
|
|
|
|
|
|
|
|
Fort McMurray, net of recoveries
|
|
2
|
|
2
|
|
|
|
|
|
|
Drug retail ancillary assets
|
|
(4)
|
|
(4)
|
|
|
112
|
|
112
|
|
Inventory losses
|
11
|
|
|
11
|
|
1
|
|
|
1
|
|
Accelerated transition of Labour Agreements
|
|
|
|
|
|
|
55
|
|
55
|
|
Charge related to inventory measurement
|
|
|
|
|
|
|
|
|
|
|
|
and other conversion differences
|
|
|
|
|
|
|
33
|
|
33
|
|
Charge related to apparel inventory
|
|
|
|
|
|
|
8
|
|
8
|
|
Shoppers Drug Mart divestitures loss
|
|
|
|
|
|
|
2
|
|
2
|
|
Modifications to certain franchise fee
|
|
|
|
|
|
|
|
|
|
|
|
arrangements
|
|
|
|
|
|
|
(8)
|
|
(8)
|
|
Foreign currency translation
|
|
|
2
|
2
|
|
|
|
(159)
|
(159)
|
Adjusting items
|
$
|
26
|
$
|
752
|
$
|
2
|
$
|
780
|
|
$
|
25
|
$
|
892
|
$
|
(159)
|
$
|
758
|
Adjusted operating income
|
$
|
199
|
$
|
2,836
|
|
$
|
3,035
|
|
$
|
202
|
$
|
2,485
|
|
|
$
|
2,687
|
Depreciation and amortization excluding the
|
|
|
|
|
|
|
|
|
|
|
impact of the above adjustments(ii)
|
97
|
1,008
|
|
1,105
|
|
83
|
1,056
|
|
1,139
|
Adjusted EBITDA
|
$
|
296
|
$
|
3,844
|
|
$
|
4,140
|
|
$
|
285
|
$
|
3,541
|
|
|
$
|
3,826
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Represents the effect of foreign currency translation on a portion of the
U.S. dollar denominated cash and cash equivalents and short term investments held by foreign operations.
|
(ii)
|
Depreciation and amortization for the calculation of adjusted EBITDA
excludes $535 million (2015 – $536 million) of amortization of intangible assets, acquired with Shoppers
Drug Mart, recorded by Loblaw and $14 million (2015 – $11 million) of accelerated depreciation recorded by
Weston Foods, related to restructuring and other charges.
|
|
|
Adjusted Net Interest Expense and Other Financing Charges The Company believes adjusted net interest expense and
other financing charges is useful in assessing the ongoing net financing costs of the Company.
The following table reconciles adjusted net interest expense and other financing charges to GAAP net interest expense and
other financing charges reported for the periods ended as indicated.
(unaudited)
($ millions)
|
|
Quarters Ended
|
Years Ended
|
|
Dec. 31, 2016
|
Dec. 31, 2015
|
Dec. 31, 2016
|
Dec. 31, 2015
|
Net interest expense and other financing charges
|
|
$
|
177
|
$
|
139
|
$
|
700
|
$
|
681
|
Add:
|
Fair value adjustment of the Trust Unit liability
|
|
1
|
(5)
|
(79)
|
(55)
|
|
Fair value adjustment of the forward sale agreement for
|
|
|
|
|
|
|
|
9.6 million Loblaw common shares
|
|
(43)
|
9
|
(53)
|
(26)
|
|
Accelerated amortization of deferred financing costs
|
|
|
|
|
(15)
|
Adjusted net interest expense and other financing charges
|
|
$
|
135
|
$
|
143
|
$
|
568
|
$
|
585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Income Taxes and Adjusted Income Tax Rate The Company believes the adjusted income tax rate applicable
to adjusted earnings before taxes is useful in assessing the underlying operating performance of its business.
The following table reconciles the effective income tax rate applicable to adjusted earnings before taxes to the GAAP
effective income tax rate applicable to earnings before taxes as reported for the periods ended as indicated.
(unaudited)
|
Quarters Ended
|
|
Years Ended
|
($ millions except where otherwise indicated)
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015(3)
|
Adjusted operating income(i)
|
$
|
762
|
|
$
|
675
|
|
$
|
3,035
|
|
$
|
2,687
|
Adjusted net interest expense and other
financing charges(i)
|
|
135
|
|
|
143
|
|
|
568
|
|
|
585
|
Adjusted earnings before taxes
|
$
|
627
|
|
$
|
532
|
|
$
|
2,467
|
|
$
|
2,102
|
Income taxes
|
$
|
83
|
|
$
|
66
|
|
$
|
465
|
|
$
|
418
|
Add:
|
Tax impact of items excluded from adjusted earnings
|
|
|
|
|
|
|
|
|
|
|
|
|
before taxes(ii)
|
|
89
|
|
|
78
|
|
|
216
|
|
|
232
|
|
Statutory corporate income tax rate change
|
|
|
|
|
|
|
|
(3)
|
|
|
(79)
|
Adjusted income taxes
|
$
|
172
|
|
$
|
144
|
|
$
|
678
|
|
$
|
571
|
Effective income tax rate applicable to earnings
before taxes
|
|
26.4%
|
|
|
23.4%
|
|
|
29.9%
|
|
|
33.5%
|
Adjusted income tax rate applicable to adjusted earnings
|
|
|
|
|
|
|
|
|
|
before taxes
|
|
27.4%
|
|
|
27.1%
|
|
|
27.5%
|
|
|
27.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
See reconciliations of adjusted operating income and adjusted net interest
expense and other financing charges above.
|
(ii)
|
See the adjusted EBITDA table and the adjusted net interest expense and
other financing charges table above for a complete list of items excluded from adjusted earnings before taxes.
|
|
|
Adjusted Net Earnings Available to Common Shareholders and Adjusted Diluted Net Earnings per Common Share The
Company believes adjusted net earnings available to common shareholders and adjusted diluted net earnings per common share are
useful in assessing the Company's underlying operating performance and in making decisions regarding the ongoing operations of
its business.
The following table reconciles net earnings attributable to shareholders of the Company to net earnings available to common
shareholders of the Company and then to adjusted net earnings available to common shareholders of the Company reported for the
periods ended as indicated.
(unaudited)
|
Quarters Ended
|
|
Years Ended
|
($ millions except where otherwise indicated)
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015(3)
|
Net earnings attributable to shareholders of the Company
|
|
$
|
92
|
|
$
|
148
|
|
$
|
550
|
|
$
|
511
|
Less:
|
Prescribed dividends on preferred shares in share capital
|
|
(10)
|
|
(10)
|
|
(44)
|
|
|
(44)
|
Net earnings available to common shareholders
of the Company
|
|
$
|
82
|
|
$
|
138
|
|
$
|
506
|
|
$
|
467
|
Reduction in net earnings due to dilution at Loblaw
|
|
|
|
|
|
|
|
5
|
|
|
3
|
Net earnings available to common shareholders for diluted earnings per
share
|
|
$
|
82
|
|
$
|
138
|
|
$
|
501
|
|
$
|
464
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings attributable to shareholders of the Company
|
|
$
|
92
|
|
$
|
148
|
|
$
|
550
|
|
$
|
511
|
Adjusting items (refer to the following table)
|
|
122
|
|
45
|
|
332
|
|
|
250
|
Adjusted net earnings attributable to shareholders
of the Company
|
|
$
|
214
|
|
$
|
193
|
|
$
|
882
|
|
$
|
761
|
Less:
|
Prescribed dividends on preferred shares in share capital
|
|
(10)
|
|
(10)
|
|
(44)
|
|
|
(44)
|
Adjusted net earnings available to common shareholders
of the Company
|
|
$
|
204
|
|
$
|
183
|
|
$
|
838
|
|
$
|
717
|
Reduction in net earnings due to dilution at Loblaw
|
|
|
|
|
|
|
|
5
|
|
|
3
|
Adjusted net earnings available to common shareholders for diluted earnings
per share
|
|
$
|
204
|
|
$
|
183
|
|
$
|
833
|
|
$
|
714
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
outstanding (millions)(i)
|
|
128.2
|
|
128.2
|
|
128.3
|
|
128.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Includes impact of dilutive instruments for purposes of calculating
adjusted diluted net earnings per common share.
|
|
|
The following table reconciles adjusted net earnings available to common shareholders of the Company and adjusted diluted net
earnings per common share to GAAP net earnings available to common shareholders of the Company and diluted net earnings per
common share as reported for the periods ended as indicated.
|
|
Quarters Ended
|
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
(unaudited)
($ except where otherwise indicated)
|
Net Earnings
Available to
Common
Shareholders of
the Company
($ millions)
|
|
Diluted
Net
Earnings
Per
Common
Share
|
|
Net Earnings
Available to
Common
Shareholders of
the Company
($ millions)
|
|
Diluted
Net
Earnings
Per
Common
Share
|
As reported
|
|
$
|
82
|
|
$
|
0.64
|
|
|
$
|
138
|
|
$
|
1.08
|
Add (deduct) impact of the following(i):
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets acquired with Shoppers Drug
Mart
|
|
41
|
|
0.33
|
|
|
42
|
|
0.32
|
|
Asset impairments, net of recoveries
|
|
44
|
|
0.34
|
|
|
2
|
|
0.02
|
|
Restructuring and other charges
|
|
4
|
|
0.03
|
|
|
3
|
|
0.01
|
|
Pension annuities and buy-outs
|
|
7
|
|
0.05
|
|
|
5
|
|
0.04
|
|
Fair value adjustment of derivatives
|
|
(3)
|
|
(0.02)
|
|
|
(6)
|
|
(0.04)
|
|
Charges related to retail locations in Fort McMurray, net of
recoveries
|
|
(1)
|
|
(0.01)
|
|
|
|
|
|
|
Drug retail ancillary assets
|
|
|
|
|
|
|
37
|
|
0.28
|
|
Inventory loss
|
|
2
|
|
0.02
|
|
|
|
|
|
|
Accelerated transition of Labour Agreements
|
|
|
|
|
|
|
|
18
|
|
0.14
|
|
Charge related to inventory measurement and other conversion
differences
|
|
|
|
|
|
|
11
|
|
0.09
|
|
Modifications to certain franchise fee arrangements
|
|
|
|
|
|
|
(4)
|
|
(0.03)
|
|
Fair value adjustment of the forward sale agreement for 9.6 million Loblaw
common shares
|
|
32
|
|
0.24
|
|
|
(7)
|
|
(0.05)
|
|
Fair value adjustment of the Trust Unit liability
|
|
1
|
|
0.01
|
|
|
1
|
|
0.01
|
|
Foreign currency translation
|
|
(5)
|
|
(0.04)
|
|
|
(57)
|
|
(0.44)
|
Adjusting items
|
|
$
|
122
|
|
$
|
0.95
|
|
|
$
|
45
|
|
$
|
0.35
|
Adjusted
|
|
$
|
204
|
|
$
|
1.59
|
|
|
$
|
183
|
|
$
|
1.43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Net of income taxes and non-controlling interests, as
applicable.
|
|
|
|
|
Years Ended
|
|
|
Dec. 31, 2016
|
|
|
Dec. 31, 2015(3)
|
(unaudited)
($ except where otherwise indicated)
|
Net Earnings
Available to
Common
Shareholders of
the Company
($ millions)
|
|
Diluted
Net
Earnings
Per
Common
Share
|
|
Net Earnings
Available to
Common
Shareholders of
the Company
($ millions)
|
|
Diluted
Net
Earnings
Per
Common
Share
|
As reported
|
|
$
|
506
|
|
$
|
3.90
|
|
|
$
|
467
|
|
$
|
3.62
|
Add (deduct) impact of the following(i):
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets acquired with Shoppers Drug
Mart
|
|
182
|
|
1.42
|
|
|
179
|
|
1.40
|
|
Asset impairments, net of recoveries
|
|
46
|
|
0.35
|
|
|
5
|
|
0.04
|
|
Restructuring and other charges
|
|
28
|
|
0.22
|
|
|
75
|
|
0.58
|
|
Pension annuities and buy-outs
|
|
10
|
|
0.08
|
|
|
5
|
|
0.04
|
|
Prior year tax assessment
|
|
3
|
|
0.02
|
|
|
|
|
|
|
Fair value adjustment of derivatives
|
|
(1)
|
|
(0.01)
|
|
|
(11)
|
|
(0.08)
|
|
Charges related to retail locations in Fort McMurray, net of
recoveries
|
|
1
|
|
0.01
|
|
|
|
|
|
|
Drug retail ancillary assets
|
|
(1)
|
|
(0.01)
|
|
|
37
|
|
0.28
|
|
Inventory losses
|
|
6
|
|
0.05
|
|
|
1
|
|
0.01
|
|
Accelerated transition of Labour Agreements
|
|
|
|
|
|
|
18
|
|
0.14
|
|
Charge related to inventory measurement and other conversion
differences
|
|
|
|
|
|
|
11
|
|
0.09
|
|
Charge related to apparel inventory
|
|
|
|
|
|
|
3
|
|
0.02
|
|
Shoppers Drug Mart divestitures loss
|
|
|
|
|
|
|
1
|
|
0.01
|
|
Modifications to certain franchise fee arrangements
|
|
|
|
|
|
|
(4)
|
|
(0.03)
|
|
Fair value adjustment of the forward sale agreement for 9.6 million Loblaw
common shares
|
|
39
|
|
0.31
|
|
|
19
|
|
0.15
|
|
Fair value adjustment of the Trust Unit liability
|
|
16
|
|
0.12
|
|
|
11
|
|
0.09
|
|
Accelerated amortization of deferred financing costs
|
|
|
|
|
|
|
5
|
|
0.04
|
|
Statutory corporate income tax rate change
|
|
1
|
|
0.01
|
|
|
41
|
|
0.31
|
|
Foreign currency translation
|
|
2
|
|
0.02
|
|
|
(146)
|
|
(1.14)
|
Adjusting items
|
|
$
|
332
|
|
$
|
2.59
|
|
|
$
|
250
|
|
$
|
1.95
|
Adjusted
|
|
$
|
838
|
|
$
|
6.49
|
|
|
$
|
717
|
|
$
|
5.57
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Net of income taxes and non-controlling interests, as
applicable.
|
|
|
FORWARD-LOOKING STATEMENTS
This News Release contains forward-looking statements about the Company's objectives, plans, goals, aspirations,
strategies, financial condition, results of operations, cash flows, performance, prospects and opportunities. Specific
forward-looking statements in this News Release include, but are not limited to, statements with respect to the Company's
anticipated future results, events and plans, synergies and other benefits associated with the acquisition of Shoppers Drug Mart
and other strategic initiatives, anticipated insurance recoveries and planned capital investments. These specific forward-looking
statements are contained throughout this News Release including, without limitation, in the "Outlook" section of this News
Release. Forward-looking statements are typically identified by words such as "expect", "anticipate", "believe", "foresee",
"could", "estimate", "goal", "intend", "plan", "seek", "strive", "will", "may", "maintain", "achieve", "grow", and "should" and
similar expressions, as they relate to the Company and its management.
Forward-looking statements reflect the Company's current estimates, beliefs and assumptions, which are based on management's
perception of historical trends, current conditions and expected future developments, as well as other factors it believes are
appropriate in the circumstances. The Company's expectation of operating and financial performance in 2017 is based on certain
assumptions including assumptions about sales and volume growth, anticipated cost savings, operating efficiencies, and continued
growth from current initiatives. The Company's estimates, beliefs and assumptions are inherently subject to significant business,
economic, competitive and other uncertainties and contingencies regarding future events and as such, are subject to change. The
Company can give no assurance that such estimates, beliefs and assumptions will prove to be correct.
Numerous risks and uncertainties could cause the Company's actual results to differ materially from those expressed, implied
or projected in the forward-looking statements, including those described in Section 12, "Enterprise Risks and Risk
Management", of the MD&A of the Company's 2016 Annual Report and the Company's Annual Information Form ("AIF") for the year
ended December 31, 2016. Such risks and uncertainties include:
- changes to the regulation of generic prescription drug prices, the reduction of reimbursements under public drug benefit
plans and the elimination or reduction of professional allowances paid by drug manufacturers;
- failure to effectively manage Loblaw's loyalty programs;
- the inability of the Company's IT infrastructure to support the requirements of the Company's business, or the occurrence
of any internal or external security breaches, denial of service attacks, viruses, worms and other known or unknown
cybersecurity or data breaches;
- failure to realize benefits from investments in the Company's new IT systems;
- failure to effectively respond to consumer trends or heightened competition, whether from current competitors or new
entrants to the marketplace;
- public health events including those related to food and drug safety;
- changes to any of the laws, rules, regulations or policies applicable to the Company's business;
- failure to merchandise effectively, to execute Loblaw's e-commerce initiative or to adapt its business model to the shifts
in the retail landscape caused by digital advances;
- failure to realize the anticipated benefits, including revenue growth, anticipated cost savings or operating efficiencies,
associated with the Company's investment in major initiatives that support its strategic priorities;
- changes in economic conditions, including economic recession or changes in the rate of inflation or deflation, employment
rates and household debt, interest rates, currency exchange rates and derivative or commodity prices;
- failure to achieve desired results in labour negotiations, including the terms of future collective bargaining
agreements;
- adverse outcomes of legal and regulatory proceedings and related matters;
- reliance on the performance and retention of third party service providers, including those associated with the Company's
supply chain and Loblaw's apparel business, including issues with vendors in both advanced and developing markets;
- the inability of the Company to manage inventory to minimize the impact of obsolete or excess inventory and to control
shrink;
- the inability of the Company to effectively develop and execute its strategy; and
- the inability of the Company to anticipate, identify and react to consumer and retail trends.
This is not an exhaustive list of the factors that may affect the Company's forward-looking statements. Other risks and
uncertainties not presently known to the Company or that the Company presently believes are not material could also cause actual
results or events to differ materially from those expressed in its forward-looking statements. Additional risks and uncertainties
are discussed in the Company's materials filed with the Canadian securities regulatory authorities from time to time, including
without limitation, the section entitled "Operating and Financial Risks and Risk Management" in the Company's AIF for the year
ended December 31, 2016. Readers are cautioned not to place undue reliance on these forward-looking statements, which
reflect the Company's expectations only as of the date of this News Release. Except as required by law, the Company does not
undertake to update or revise any forward-looking statements, whether as a result of new information, future events or
otherwise.
SELECTED FINANCIAL INFORMATION
The following includes selected quarterly financial information which is prepared by management in accordance with
International Financial Reporting Standards ("IFRS") and is based on the Company's audited annual consolidated financial
statements for the year ended December 31, 2016. This financial information does not contain all disclosures required by
IFRS, and accordingly, this financial information should be read in conjunction with the Company's 2016 Annual Report available
in the Investor Centre section of the Company's website at www.weston.ca.
Condensed Consolidated Statements of Earnings
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(millions of Canadian dollars except where otherwise indicated)
|
Dec. 31, 2016
|
|
|
Dec. 31, 2015
|
|
|
Dec. 31, 2016
|
|
|
Dec. 31, 2015(3)
|
|
|
For the periods ended as indicated
|
|
(12 weeks)
|
|
|
|
(12 weeks)
|
|
|
|
(52 weeks)
|
|
|
|
(52 weeks)
|
|
|
Revenue
|
|
$
|
11,519
|
|
|
|
$
|
11,248
|
|
|
|
$
|
47,999
|
|
|
|
$
|
46,894
|
|
|
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of inventories sold
|
|
8,143
|
|
|
|
8,046
|
|
|
|
34,108
|
|
|
|
33,667
|
|
|
|
Selling, general and administrative expenses
|
|
2,885
|
|
|
|
2,781
|
|
|
|
11,636
|
|
|
|
11,298
|
|
|
|
|
11,028
|
|
|
|
10,827
|
|
|
|
45,744
|
|
|
|
44,965
|
|
|
Operating Income
|
|
491
|
|
|
|
421
|
|
|
|
2,255
|
|
|
|
1,929
|
|
|
|
Net Interest Expense and Other Financing Charges
|
|
177
|
|
|
|
139
|
|
|
|
700
|
|
|
|
681
|
|
|
Earnings Before Income Taxes
|
|
314
|
|
|
|
282
|
|
|
|
1,555
|
|
|
|
1,248
|
|
|
|
Income Tax
|
|
83
|
|
|
|
66
|
|
|
|
465
|
|
|
|
418
|
|
|
Net Earnings
|
|
231
|
|
|
|
216
|
|
|
|
1,090
|
|
|
|
830
|
|
|
Attributable to:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders of the Company
|
|
92
|
|
|
|
148
|
|
|
|
550
|
|
|
|
511
|
|
|
|
Non-Controlling Interests
|
|
139
|
|
|
|
68
|
|
|
|
540
|
|
|
|
319
|
|
|
Net Earnings
|
|
$
|
231
|
|
|
|
$
|
216
|
|
|
|
$
|
1,090
|
|
|
|
$
|
830
|
|
|
Net Earnings per Common Share ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.64
|
|
|
|
$
|
1.08
|
|
|
|
$
|
3.96
|
|
|
|
$
|
3.66
|
|
|
|
Diluted
|
|
$
|
0.64
|
|
|
|
$
|
1.08
|
|
|
|
$
|
3.90
|
|
|
|
$
|
3.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets
As at December 31
|
|
|
|
|
|
|
|
|
(millions of Canadian dollars)
|
2016
|
|
|
2015(3)
|
|
|
ASSETS
|
|
|
|
|
|
|
Current Assets
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
1,560
|
|
|
|
$
|
1,413
|
|
|
|
Short term investments
|
|
1,011
|
|
|
|
1,166
|
|
|
|
Accounts receivable
|
|
1,284
|
|
|
|
1,478
|
|
|
|
Credit card receivables
|
|
2,926
|
|
|
|
2,790
|
|
|
|
Inventories
|
|
4,559
|
|
|
|
4,517
|
|
|
|
Prepaid expenses and other
assets
|
|
201
|
|
|
|
279
|
|
|
|
Assets held for sale
|
|
40
|
|
|
|
71
|
|
|
Total Current Assets
|
|
11,581
|
|
|
|
11,714
|
|
|
Fixed Assets
|
|
11,534
|
|
|
|
11,352
|
|
|
Investment Properties
|
|
218
|
|
|
|
160
|
|
|
Intangible Assets
|
|
8,875
|
|
|
|
9,292
|
|
|
Goodwill
|
|
4,364
|
|
|
|
4,254
|
|
|
Deferred Income Taxes
|
|
201
|
|
|
|
156
|
|
|
Security Deposits
|
|
89
|
|
|
|
88
|
|
|
Franchise Loans Receivable
|
|
233
|
|
|
|
329
|
|
|
Other Assets
|
|
851
|
|
|
|
875
|
|
|
Total Assets
|
|
$
|
37,946
|
|
|
|
$
|
38,220
|
|
|
LIABILITIES
|
|
|
|
|
|
|
Current Liabilities
|
|
|
|
|
|
|
|
Bank indebtedness
|
|
$
|
115
|
|
|
|
$
|
143
|
|
|
|
Trade payables and other liabilities
|
|
5,356
|
|
|
|
5,381
|
|
|
|
Provisions
|
|
135
|
|
|
|
180
|
|
|
|
Income taxes payable
|
|
341
|
|
|
|
73
|
|
|
|
Short term debt
|
|
1,241
|
|
|
|
1,086
|
|
|
|
Long term debt due within one year
|
|
400
|
|
|
|
1,348
|
|
|
|
Associate interest
|
|
243
|
|
|
|
216
|
|
|
Total Current Liabilities
|
|
7,831
|
|
|
|
8,427
|
|
|
Provisions
|
|
146
|
|
|
|
157
|
|
|
Long Term Debt
|
|
11,385
|
|
|
|
10,928
|
|
|
Trust Unit Liability
|
|
635
|
|
|
|
552
|
|
|
Deferred Income Taxes
|
|
2,370
|
|
|
|
2,448
|
|
|
Other Liabilities
|
|
789
|
|
|
|
818
|
|
|
Total Liabilities
|
|
23,156
|
|
|
|
23,330
|
|
|
EQUITY
|
|
|
|
|
|
|
Share Capital
|
|
1,012
|
|
|
|
1,008
|
|
|
Retained Earnings
|
|
6,704
|
|
|
|
6,422
|
|
|
Contributed Surplus
|
|
(156)
|
|
|
|
20
|
|
|
Accumulated Other Comprehensive Income
|
|
204
|
|
|
|
231
|
|
|
Total Equity Attributable to Shareholders of the Company
|
|
7,764
|
|
|
|
7,681
|
|
|
Non-Controlling Interests
|
|
7,026
|
|
|
|
7,209
|
|
|
Total Equity
|
|
14,790
|
|
|
|
14,890
|
|
|
Total Liabilities and Equity
|
|
$
|
37,946
|
|
|
|
$
|
38,220
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
(millions of Canadian dollars)
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015(3)
|
For the periods ended as indicated
|
|
(12 weeks)
|
|
(12 weeks)
|
|
(52 weeks)
|
|
(52 weeks)
|
Operating Activities
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
231
|
|
$
|
216
|
|
$
|
1,090
|
|
$
|
830
|
|
Add:
|
|
|
|
|
|
|
|
|
|
Net interest expense and other financing charges
|
|
177
|
|
139
|
|
700
|
|
681
|
|
Income taxes
|
|
83
|
|
66
|
|
465
|
|
418
|
|
Depreciation and amortization
|
|
392
|
|
401
|
|
1,654
|
|
1,686
|
|
Charge related to inventory measurement and other conversion
differences
|
|
|
|
4
|
|
|
|
4
|
|
Asset impairments, net of recoveries
|
|
130
|
|
26
|
|
142
|
|
73
|
|
Foreign currency translation (gain) loss
|
|
(6)
|
|
(65)
|
|
2
|
|
(159)
|
|
|
1,007
|
|
787
|
|
4,053
|
|
3,533
|
|
Change in credit card receivables
|
|
(157)
|
|
(127)
|
|
(136)
|
|
(160)
|
|
Change in non-cash working capital
|
|
144
|
|
158
|
|
108
|
|
220
|
|
Income taxes paid
|
|
(52)
|
|
(66)
|
|
(345)
|
|
(263)
|
|
Interest received
|
|
4
|
|
3
|
|
15
|
|
13
|
|
Other
|
|
30
|
|
(71)
|
|
65
|
|
24
|
Cash Flows from Operating Activities
|
|
976
|
|
684
|
|
3,760
|
|
3,367
|
Investing Activities
|
|
|
|
|
|
|
|
|
|
Fixed asset purchases
|
|
(452)
|
|
(421)
|
|
(1,129)
|
|
(1,267)
|
|
Intangible asset additions
|
|
(116)
|
|
(104)
|
|
(336)
|
|
(233)
|
|
Acquisition of QHR, net of cash acquired
|
|
(153)
|
|
|
|
(153)
|
|
|
|
Cash assumed on initial consolidation of franchises
|
|
11
|
|
31
|
|
42
|
|
33
|
|
Change in short term investments
|
|
(89)
|
|
(19)
|
|
160
|
|
57
|
|
Change in security deposits
|
|
(2)
|
|
209
|
|
(3)
|
|
10
|
|
Other
|
|
26
|
|
36
|
|
95
|
|
(7)
|
Cash Flows used in Investing Activities
|
|
(775)
|
|
(268)
|
|
(1,324)
|
|
(1,407)
|
Financing Activities
|
|
|
|
|
|
|
|
|
|
Change in bank indebtedness
|
|
(142)
|
|
(100)
|
|
(28)
|
|
(19)
|
|
Change in short term debt
|
|
200
|
|
(20)
|
|
155
|
|
(15)
|
|
Interest paid
|
|
(103)
|
|
(120)
|
|
(570)
|
|
(587)
|
|
Redemption of Loblaw capital securities
|
|
|
|
|
|
|
|
(225)
|
|
Long term debt
|
– Issued
|
|
159
|
|
338
|
|
815
|
|
1,186
|
|
|
– Retired
|
|
(380)
|
|
(502)
|
|
(1,399)
|
|
(1,783)
|
|
Share capital
|
– Issued
|
|
1
|
|
1
|
|
4
|
|
9
|
|
|
– Purchased and held in trusts
|
|
|
|
|
|
(11)
|
|
(7)
|
|
|
– Purchased and cancelled
|
|
(2)
|
|
|
|
(8)
|
|
(14)
|
|
Loblaw common share capital
|
– Issued
|
|
4
|
|
15
|
|
42
|
|
63
|
|
|
– Purchased and held in trusts
|
|
|
|
(6)
|
|
(90)
|
|
(63)
|
|
|
– Purchased and cancelled
|
|
(200)
|
|
(186)
|
|
(708)
|
|
(280)
|
|
Loblaw preferred share capital
|
– Issued
|
|
|
|
|
|
|
|
221
|
|
Dividends
|
– To common shareholders
|
|
|
|
|
|
(221)
|
|
(162)
|
|
|
– To preferred shareholders
|
|
(3)
|
|
(3)
|
|
(44)
|
|
(36)
|
|
|
– To minority shareholders
|
|
(56)
|
|
(57)
|
|
(232)
|
|
(229)
|
|
Other
|
|
16
|
|
16
|
|
20
|
|
23
|
Cash Flows used in Financing Activities
|
|
(506)
|
|
(624)
|
|
(2,275)
|
|
(1,918)
|
Effect of foreign currency exchange rate changes on cash and cash
equivalents
|
|
2
|
|
16
|
|
(14)
|
|
38
|
Change in Cash and Cash Equivalents
|
|
(303)
|
|
(192)
|
|
147
|
|
80
|
Cash and Cash Equivalents, Beginning of Period
|
|
1,863
|
|
1,605
|
|
1,413
|
|
1,333
|
Cash and Cash Equivalents, End of Period
|
|
$
|
1,560
|
|
$
|
1,413
|
|
$
|
1,560
|
|
$
|
1,413
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and Diluted Net Earnings per Common Share
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
(millions of Canadian dollars except where otherwise indicated)
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015
|
|
Dec. 31, 2016
|
|
Dec. 31, 2015(3)
|
For the periods ended as indicated
|
|
(12 weeks)
|
|
(12 weeks)
|
|
(52 weeks)
|
|
(52 weeks)
|
Net earnings attributable to shareholders
of the Company
|
|
$
|
92
|
|
$
|
148
|
|
$
|
550
|
|
$
|
511
|
Prescribed dividends on preferred shares
in share capital
|
|
(10)
|
|
(10)
|
|
(44)
|
|
(44)
|
Net earnings available to common shareholders of the
Company
|
|
$
|
82
|
|
$
|
138
|
|
$
|
506
|
|
$
|
467
|
Reduction in net earnings due to dilution at Loblaw
|
|
|
|
|
|
(5)
|
|
(3)
|
Net earnings available to common shareholders
for diluted earnings per share
|
|
$
|
82
|
|
$
|
138
|
|
$
|
501
|
|
$
|
464
|
Weighted average common shares outstanding (in millions)
|
|
127.6
|
|
127.6
|
|
127.7
|
|
127.7
|
Dilutive effect of share-based compensation(i) (in
millions)
|
|
0.6
|
|
0.6
|
|
0.6
|
|
0.5
|
Weighted average common shares outstanding(ii) (in
millions)
|
|
128.2
|
|
128.2
|
|
128.3
|
|
128.2
|
Basic net earnings per common share ($)
|
|
$
|
0.64
|
|
$
|
1.08
|
|
$
|
3.96
|
|
$
|
3.66
|
Diluted net earnings per common share ($)
|
|
$
|
0.64
|
|
$
|
1.08
|
|
$
|
3.90
|
|
$
|
3.62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
In the fourth quarter of 2016 and year-to-date, 215,049 (2015 – 325,817)
and 316,643 (2015 – 347,225) potentially dilutive instruments, respectively, were excluded from the computation of
diluted net earnings per common share as they were anti-dilutive.
|
(ii)
|
Includes impact of dilutive instruments for purposes of calculating diluted
net earnings per common share.
|
|
|
Segment Information
The Company has two reportable operating segments: Weston Foods and Loblaw. The accounting policies of the reportable
operating segments are the same as those described in the Company's 2016 audited annual consolidated financial statements. The
Company measures each reportable operating segment's performance based on adjusted EBITDA(i) and adjusted operating
income(i). Neither reportable operating segment is reliant on any single external customer.
|
|
12 Weeks Ended
|
|
|
2016
|
|
|
|
2015
|
(unaudited)
(millions of Canadian dollars)
|
|
Weston
Foods
|
|
Loblaw
|
|
Other and
Intersegment(ii)
|
|
Total
|
|
Weston
Foods
|
|
Loblaw
|
|
Other and
Intersegment(ii)
|
|
Total
|
Revenue
|
|
$
|
537
|
|
$
|
11,130
|
|
$
|
(148)
|
|
$
|
11,519
|
|
$
|
527
|
|
$
|
10,865
|
|
$
|
(144)
|
|
$
|
11,248
|
Operating income
|
|
$
|
38
|
|
$
|
447
|
|
$
|
6
|
|
$
|
491
|
|
$
|
42
|
|
$
|
314
|
|
$
|
65
|
|
$
|
421
|
Net interest expense and other financing charges
|
|
52
|
|
|
128
|
|
|
(3)
|
|
177
|
|
3
|
|
141
|
|
(5)
|
|
139
|
Earnings before income tax
|
|
$
|
(14)
|
|
$
|
319
|
|
$
|
9
|
|
$
|
314
|
|
$
|
39
|
|
$
|
173
|
|
$
|
70
|
|
$
|
282
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
38
|
|
$
|
447
|
|
$
|
6
|
|
$
|
491
|
|
$
|
42
|
|
$
|
314
|
|
$
|
65
|
|
$
|
421
|
Depreciation and amortization
|
|
27
|
|
365
|
|
|
|
392
|
|
25
|
|
376
|
|
|
|
|
401
|
Adjusting items(iii)
|
|
8
|
|
142
|
|
(6)
|
|
144
|
|
|
|
189
|
|
(65)
|
|
124
|
Adjusted EBITDA(i)
|
|
$
|
73
|
|
$
|
954
|
|
|
|
|
$
|
1,027
|
|
$
|
67
|
|
$
|
879
|
|
|
|
|
$
|
946
|
Depreciation and amortization(iv)
|
|
24
|
|
241
|
|
|
|
|
265
|
|
19
|
|
252
|
|
|
|
|
271
|
Adjusted operating income (i)
|
|
$
|
49
|
|
$
|
713
|
|
|
|
|
$
|
762
|
|
$
|
48
|
|
$
|
627
|
|
|
|
|
$
|
675
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Excludes certain items and is used internally by management when analyzing
segment underlying operating performance.
|
(ii)
|
Other and intersegment includes the following items:
|
|
- intercompany revenue elimination;
- Trust Unit distributions from Choice Properties to GWL
and the elimination of the fair value adjustment of the Trust Unit liability related to GWL's direct investment in
Choice Properties recorded in net interest expense and other financing charges; and
- the effect of foreign currency translation on a portion
of the U.S. dollar denominated cash and cash equivalents and short term investments held by foreign
operations.
|
(iii)
|
The impact of certain items excluded by management includes restructuring
and other charges, fixed asset and other related impairments, net of recoveries, at Loblaw, a charge related to pension
annuities and buy-outs, the fair value adjustment of derivatives, inventory loss incurred by Weston Foods, a charge
related to drug retail ancillary assets at Loblaw, modifications to certain franchise fee arrangements at Loblaw, a
charge related to labour agreements at Loblaw, a charge related to the change in inventory measurement and other
conversion differences at Loblaw and charges related to retail locations in Fort McMurray, net of recoveries at
Loblaw.
|
(iv)
|
Excludes $124 million (2015 – $124 million) of amortization of
intangible assets acquired with Shoppers Drug Mart, recorded by Loblaw, and $3 million (2015 – $6 million) of
accelerated depreciation recorded by Weston Foods, included in restructuring and other charges.
|
|
|
|
|
52 Weeks Ended
|
|
|
|
2016
|
|
|
2015
|
(millions of Canadian dollars)
|
|
Weston
Foods
|
|
Loblaw
|
|
Other and
Intersegment(ii)
|
|
Total
|
|
Weston
Foods
|
|
Loblaw
|
|
Other and
Intersegment(ii)
|
|
Total
|
Revenue
|
|
$
|
2,268
|
|
$
|
46,385
|
|
$
|
(654)
|
|
$
|
47,999
|
|
$
|
2,144
|
|
$
|
45,394
|
|
$
|
(644)
|
|
$
|
46,894
|
Operating income
|
|
$
|
173
|
|
$
|
2,084
|
|
$
|
(2)
|
|
$
|
2,255
|
|
$
|
177
|
|
$
|
1,593
|
|
$
|
159
|
|
$
|
1,929
|
Net interest expense and other
financing charges
|
|
102
|
|
653
|
|
(55)
|
|
700
|
|
77
|
|
644
|
|
(40)
|
|
681
|
Earnings before income tax
|
|
$
|
71
|
|
$
|
1,431
|
|
$
|
53
|
|
$
|
1,555
|
|
$
|
100
|
|
$
|
949
|
|
$
|
199
|
|
$
|
1,248
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
$
|
173
|
|
$
|
2,084
|
|
$
|
(2)
|
|
$
|
2,255
|
|
$
|
177
|
|
$
|
1,593
|
|
$
|
159
|
|
$
|
1,929
|
Depreciation and amortization
|
|
111
|
|
1,543
|
|
|
|
1,654
|
|
94
|
|
1,592
|
|
|
|
1,686
|
Adjusting items(iii)
|
|
12
|
|
217
|
|
2
|
|
231
|
|
14
|
|
356
|
|
(159)
|
|
211
|
Adjusted EBITDA(i)
|
|
$
|
296
|
|
$
|
3,844
|
|
|
|
|
$
|
4,140
|
|
$
|
285
|
|
$
|
3,541
|
|
|
|
|
$
|
3,826
|
Depreciation and amortization(iv)
|
|
97
|
|
1,008
|
|
|
|
1,105
|
|
83
|
|
1,056
|
|
|
|
1,139
|
Adjusted operating income (i)
|
|
$
|
199
|
|
$
|
2,836
|
|
|
|
$
|
3,035
|
|
$
|
202
|
|
$
|
2,485
|
|
|
|
|
$
|
2,687
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(i)
|
Excludes certain items and is used internally by management when analyzing
segment underlying operating performance.
|
(ii)
|
Other and intersegment includes the following items:
|
|
- intercompany revenue elimination;
- Trust Unit distributions from Choice Properties to GWL
and the elimination of the fair value adjustment of the Trust Unit liability related to GWL's direct investment in
Choice Properties recorded in net interest expense and other financing charges; and
- the effect of foreign currency translation on a portion
of the U.S. dollar denominated cash and cash equivalents and short term investments held by foreign
operations.
|
(iii)
|
The impact of certain items excluded by management includes restructuring
and other charges, fixed asset and other related impairments, net of recoveries, at Loblaw, a charge related to pension
annuities and buy-outs, certain charges related to the acquisition of Shoppers Drug Mart, the fair value adjustment of
derivatives, inventory losses incurred by Weston Foods, a prior year tax assessment at Loblaw, a charge related to Loblaw
apparel inventory, a gain (2015 – charge) related to drug retail ancillary assets at Loblaw, modifications to certain
franchise fee arrangements at Loblaw, a charge related to labour agreements at Loblaw, a charge related to the change in
inventory measurement and other conversion differences at Loblaw and charges related to retail locations in Fort
McMurray, net of recoveries at Loblaw.
|
(iv)
|
Excludes $535 million (2015 – $536 million) of amortization of
intangible assets acquired with Shoppers Drug Mart, recorded by Loblaw, and $14 million (2015 – $11 million) of
accelerated depreciation recorded by Weston Foods, included in restructuring and other charges.
|
|
|
2016 ANNUAL AUDITED CONSOLIDATED FINANCIAL STATEMENTS AND MANAGEMENT'S DISCUSSION AND ANALYSIS
The Company's annual audited consolidated financial statements and MD&A for the year ended December 31, 2016
are available in the Investor Centre section of the Company's website at www.weston.ca and have been filed with SEDAR and are available online at www.sedar.com.
INVESTOR RELATIONS
Shareholders, security analysts and investment professionals should direct their requests to
Mr. Geoffrey H. Wilson, Senior Vice President, Investor Relations, Business Intelligence and Communications,
at the Company's Executive Office or by e-mail at investor@weston.ca.
Additional financial information has been filed electronically with various securities regulators in Canada through SEDAR. This News Release includes selected information on Loblaw Companies Limited, a public
company with shares trading on the Toronto Stock Exchange. For information regarding Loblaw, readers should also refer to the
materials filed by Loblaw with SEDAR from time to time. These filings are also maintained at Loblaw's corporate website at
www.loblaw.ca.
FOURTH QUARTER CONFERENCE CALL AND WEBCAST PRESENTATION
George Weston Limited will host a conference call as well as an audio webcast on Thursday, March 2, 2017 at
9:00 a.m. (EST). To access via tele-conference, please dial (647) 427-7450 or 1-888-231-8191. The playback will be
available two hours after the event at (416) 849-0833 or 1-855-859-2056 passcode: 77505016#. To access via audio webcast,
please visit the Investor Centre section of www.weston.ca. Pre-registration
will be available.
ANNUAL MEETING
The George Weston Limited Annual Meeting of Shareholders will be held on Tuesday, May 9,
2017, at 11:00 a.m. (EST) at The Royal Conservatory, TELUS Centre for Performance and Learning, Koerner Hall, 273 Bloor Street West, Toronto, Ontario, Canada.
|
|
Endnotes
|
|
|
(1)
|
See the "Non-GAAP Financial Measures" section of this News
Release.
|
(2)
|
This News Release contains forward-looking information. See Forward-Looking
Statements of this News Release for a discussion of material factors that could cause actual results to differ materially
from the forecasts and projections herein and of the material factors, estimates, beliefs and assumptions that were
applied in presenting the conclusions, forecasts and projections presented herein. This News Release must be read in
conjunction with GWL's filings with securities regulators made from time to time, all of which can be found at
www.weston.ca and www.sedar.com.
|
(3)
|
Certain figures have been restated as a result of the IFRS Interpretations
Committee's agenda decision on IAS 12, "Income Taxes". See note 2 of the Company's audited consolidated financial
statements included in the 2016 Annual Report.
|
|
|
SOURCE George Weston Limited
To view this news release in HTML formatting, please use the following URL:
http://www.newswire.ca/en/releases/archive/March2017/02/c4600.html